首页 > 最新文献

Surgery Today最新文献

英文 中文
Short-term outcomes of robotic subxiphoid-optical thymectomy. 机器人剑突下-光学胸腺切除术的短期疗效。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-06-24 DOI: 10.1007/s00595-024-02887-x
Masanori Shimomura, Satoru Okada, Tatsuo Furuya, Rina Oya, Yuka Hirakawa, Fumimasa Amaya, Masayoshi Inoue

Purpose: To evaluate the usefulness of robotic subxiphoid-optical thymectomy (RST).

Methods: Thirty-seven procedures (thymoma, n = 19; thymic carcinoma, n = 1; myasthenia gravis, n = 3; and others, n = 14) performed between October 2020 and December 2023 were included. The right and left 6th intercostal midclavicular lines and subxiphoid, with an assistant port placed in the right third intercostal anterior axillary line, were adapted. Postoperative pain was assessed using a numerical rating scale (NRS).

Results: A good view of the surgical field is obtained. The median console time was 113 min and the time to roll-in was 30 min. The body mass index (BMI) was 21.6. One patient with thymic carcinoma required combined resection of the left phrenic nerve and left brachiocephalic vein without conversion to thoracotomy, and 1 patient had post-pericardiotomy syndrome with bilateral pleural effusion. There was a correlation between the prolonged time to roll-in and BMI (ρ = 0.439; p = 0.007). Pain was controlled with oral medication on postoperative day 1 and significantly decreased at discharge and at the first outpatient visit without epidural anesthesia (median NRS scores: 4, 1, and 1, respectively).

Conclusion: RST is a safe procedure that provides surgeons with a sufficient view of the anterior mediastinum and causes minimal postoperative pain.

目的:评估机器人剑突下-光学胸腺切除术(RST)的实用性:纳入2020年10月至2023年12月期间进行的37例手术(胸腺瘤,19例;胸腺癌,1例;重症肌无力,3例;其他,14例)。手术采用右侧和左侧第6肋间锁骨中线和剑突下,辅助孔位于右侧第3肋间腋前线。术后疼痛采用数字评分量表(NRS)进行评估:结果:手术视野良好。中位控制台时间为 113 分钟,滚入时间为 30 分钟。体重指数(BMI)为 21.6。一名胸腺癌患者需要联合切除左侧膈神经和左侧肱静脉,但未转为开胸手术,一名患者出现心包切除术后综合征,双侧胸腔积液。卷入时间延长与体重指数之间存在相关性(ρ = 0.439; p = 0.007)。术后第1天口服药物控制了疼痛,出院时和首次门诊时疼痛明显减轻,无硬膜外麻醉(NRS评分中位数分别为4、1和1):RST是一种安全的手术,可为外科医生提供足够的前纵隔视野,术后疼痛极小。
{"title":"Short-term outcomes of robotic subxiphoid-optical thymectomy.","authors":"Masanori Shimomura, Satoru Okada, Tatsuo Furuya, Rina Oya, Yuka Hirakawa, Fumimasa Amaya, Masayoshi Inoue","doi":"10.1007/s00595-024-02887-x","DOIUrl":"10.1007/s00595-024-02887-x","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the usefulness of robotic subxiphoid-optical thymectomy (RST).</p><p><strong>Methods: </strong>Thirty-seven procedures (thymoma, n = 19; thymic carcinoma, n = 1; myasthenia gravis, n = 3; and others, n = 14) performed between October 2020 and December 2023 were included. The right and left 6th intercostal midclavicular lines and subxiphoid, with an assistant port placed in the right third intercostal anterior axillary line, were adapted. Postoperative pain was assessed using a numerical rating scale (NRS).</p><p><strong>Results: </strong>A good view of the surgical field is obtained. The median console time was 113 min and the time to roll-in was 30 min. The body mass index (BMI) was 21.6. One patient with thymic carcinoma required combined resection of the left phrenic nerve and left brachiocephalic vein without conversion to thoracotomy, and 1 patient had post-pericardiotomy syndrome with bilateral pleural effusion. There was a correlation between the prolonged time to roll-in and BMI (ρ = 0.439; p = 0.007). Pain was controlled with oral medication on postoperative day 1 and significantly decreased at discharge and at the first outpatient visit without epidural anesthesia (median NRS scores: 4, 1, and 1, respectively).</p><p><strong>Conclusion: </strong>RST is a safe procedure that provides surgeons with a sufficient view of the anterior mediastinum and causes minimal postoperative pain.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"205-210"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Specialized educational program for high-grade liver injury management: a three-dimensional printed model approach. 高级肝损伤管理的专门教育计划:三维打印模型方法。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-08-10 DOI: 10.1007/s00595-024-02911-0
David Aranovich, Yifat Fainzilber Goldman, Neev Tchernin, Ricardo Alfici, Mickey Dudkiewicz, Mansoor Khan, Yoram Ohana, Boris Kessel

Purpose: The study aims to present a specialized educational program using a 3D printed model for managing Grade IV and V liver injuries. Hepatic packing, a common technique, may not always achieve sufficient hemostasis in these cases, warranting alternative solutions such as mesh liver wrapping. However, mastering this procedure is challenging due to limited teaching resources and the need for repeated practice.

Methods: A computer-based model was created from an abdominal CT scan to produce a real-sized injured liver model using thermoplastic elastomer TPU-95. Trainees received systematic instruction from an instructor, allowing them to perform the procedure under supervision and independently.

Results: Eight surgical residents at Hillel Yaffe Medical Center participated in the program, with the majority successfully completing the procedure under supervision. Furthermore, trainees demonstrated reduced procedure times when performing independently, indicating improved proficiency.

Conclusion: This educational approach offers a simple and repeatable method for continuous training in managing high-grade liver injuries, holding potential for enhanced patient outcomes.

目的:本研究旨在介绍一种使用 3D 打印模型处理 IV 级和 V 级肝损伤的专业教育计划。肝脏包扎是一种常用技术,但在这些病例中不一定能实现充分止血,因此需要采用网状肝脏包扎等替代解决方案。然而,由于教学资源有限且需要反复练习,掌握这种手术方法具有挑战性:方法:使用热塑性弹性体 TPU-95 通过腹部 CT 扫描创建基于计算机的模型,以制作真实大小的受伤肝脏模型。受训人员接受教师的系统指导,在监督下独立完成手术:结果:希勒尔-亚夫医疗中心的八名外科住院医师参加了该项目,其中大部分人在指导下成功完成了手术。此外,受训者在独立完成手术时缩短了手术时间,表明他们的熟练程度有所提高:这种教育方法为处理高级别肝损伤的持续培训提供了一种简单且可重复的方法,有望提高患者的治疗效果。
{"title":"Specialized educational program for high-grade liver injury management: a three-dimensional printed model approach.","authors":"David Aranovich, Yifat Fainzilber Goldman, Neev Tchernin, Ricardo Alfici, Mickey Dudkiewicz, Mansoor Khan, Yoram Ohana, Boris Kessel","doi":"10.1007/s00595-024-02911-0","DOIUrl":"10.1007/s00595-024-02911-0","url":null,"abstract":"<p><strong>Purpose: </strong>The study aims to present a specialized educational program using a 3D printed model for managing Grade IV and V liver injuries. Hepatic packing, a common technique, may not always achieve sufficient hemostasis in these cases, warranting alternative solutions such as mesh liver wrapping. However, mastering this procedure is challenging due to limited teaching resources and the need for repeated practice.</p><p><strong>Methods: </strong>A computer-based model was created from an abdominal CT scan to produce a real-sized injured liver model using thermoplastic elastomer TPU-95. Trainees received systematic instruction from an instructor, allowing them to perform the procedure under supervision and independently.</p><p><strong>Results: </strong>Eight surgical residents at Hillel Yaffe Medical Center participated in the program, with the majority successfully completing the procedure under supervision. Furthermore, trainees demonstrated reduced procedure times when performing independently, indicating improved proficiency.</p><p><strong>Conclusion: </strong>This educational approach offers a simple and repeatable method for continuous training in managing high-grade liver injuries, holding potential for enhanced patient outcomes.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"283-287"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreas-left gastric artery angle predicts difficulty of suprapancreatic lymph node dissection in gastrectomy for gastric cancer: a cross-sectional study. 胰腺-胃左动脉角度预测胃癌胃切除术中胰上淋巴结清扫的难度:一项横断面研究。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-16 DOI: 10.1007/s00595-024-02890-2
Ryugo Teranishi, Tsuyoshi Takahashi, Yukinori Kurokawa, Takuro Saito, Kazuyoshi Yamamoto, Kota Momose, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Kiyokazu Nakajima, Hidetoshi Eguchi, Yuichiro Doki

Purpose: Suprapancreatic lymph node dissection is one of the most challenging procedures performed in the treatment of gastric cancer. This study aimed to investigate whether the pancreas-left gastric artery angle (PLA) can be used to predict the difficulty of the procedure.

Methods: This was a single-center cross-sectional study. Before gastrectomy, the patients were classified according to the size of the PLA into the small PLA (s-PLA; < 30°) and large PLA (l-PLA; ≥ 30°) groups in a surgeon-blinded manner. After gastrectomy, a surgeon evaluated suprapancreatic lymph node dissection as hard, normal, or easy to perform.

Results: Seventy-three patients were enrolled in the study. Surgeons evaluated lymph node dissection as hard in 43.8 and 8.7% of patients in the s-PLA and l-PLA groups, respectively (p = 0.002). The time taken for suprapancreatic lymph node dissection was also significantly longer in the s-PLA group than in the l-PLA group (p = 0.040). In patients who underwent laparoscopic gastrectomy, the time for node dissection in the s-PLA group was also significantly longer than that in the s-PLA group (p = 0.021), while there was no difference in those who underwent robotic surgery (p = 0.815).

Conclusion: PLA is useful for predicting the degree of difficulty of suprapancreatic lymph node dissection during gastrectomy for gastric cancer.

目的:胰上淋巴结清扫术是胃癌治疗中最具挑战性的手术之一。本研究旨在探讨胰腺-胃左动脉角(PLA)是否可用于预测手术难度:这是一项单中心横断面研究。方法:这是一项单中心横断面研究。胃切除术前,根据胰左动脉角的大小将患者分为小胰左动脉角(s-PLA)和大胰左动脉角(s-PLA)两类:73名患者参与了研究。外科医生认为小PLA组和大PLA组分别有43.8%和8.7%的患者难以进行淋巴结清扫(P = 0.002)。胰上淋巴结清扫所需的时间,s-PLA 组也明显长于 l-PLA 组(p = 0.040)。在接受腹腔镜胃切除术的患者中,s-PLA组的淋巴结清扫时间也明显长于s-PLA组(p = 0.021),而接受机器人手术的患者则没有差异(p = 0.815):结论:PLA可用于预测胃癌胃切除术中胰上淋巴结清扫的难度。
{"title":"Pancreas-left gastric artery angle predicts difficulty of suprapancreatic lymph node dissection in gastrectomy for gastric cancer: a cross-sectional study.","authors":"Ryugo Teranishi, Tsuyoshi Takahashi, Yukinori Kurokawa, Takuro Saito, Kazuyoshi Yamamoto, Kota Momose, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Kiyokazu Nakajima, Hidetoshi Eguchi, Yuichiro Doki","doi":"10.1007/s00595-024-02890-2","DOIUrl":"10.1007/s00595-024-02890-2","url":null,"abstract":"<p><strong>Purpose: </strong>Suprapancreatic lymph node dissection is one of the most challenging procedures performed in the treatment of gastric cancer. This study aimed to investigate whether the pancreas-left gastric artery angle (PLA) can be used to predict the difficulty of the procedure.</p><p><strong>Methods: </strong>This was a single-center cross-sectional study. Before gastrectomy, the patients were classified according to the size of the PLA into the small PLA (s-PLA; < 30°) and large PLA (l-PLA; ≥ 30°) groups in a surgeon-blinded manner. After gastrectomy, a surgeon evaluated suprapancreatic lymph node dissection as hard, normal, or easy to perform.</p><p><strong>Results: </strong>Seventy-three patients were enrolled in the study. Surgeons evaluated lymph node dissection as hard in 43.8 and 8.7% of patients in the s-PLA and l-PLA groups, respectively (p = 0.002). The time taken for suprapancreatic lymph node dissection was also significantly longer in the s-PLA group than in the l-PLA group (p = 0.040). In patients who underwent laparoscopic gastrectomy, the time for node dissection in the s-PLA group was also significantly longer than that in the s-PLA group (p = 0.021), while there was no difference in those who underwent robotic surgery (p = 0.815).</p><p><strong>Conclusion: </strong>PLA is useful for predicting the degree of difficulty of suprapancreatic lymph node dissection during gastrectomy for gastric cancer.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"180-187"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcomes of below-the-knee bypass surgery using heparin-bonded expanded polytetrafluoroethylene grafts. 使用肝素粘合膨体聚四氟乙烯移植物进行膝下搭桥手术的长期疗效。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-17 DOI: 10.1007/s00595-024-02898-8
Yohei Yamamoto, Hidetoshi Uchiyama, Masahiro Oonuki, Kazuki Tsukuda, Ai Kazama, Yoshiki Wada, Hiroki Uchiyama, Toru Kikuchi, Masato Nishizawa, Toshifumi Kudo

Purpose: To report the outcomes of below-the-knee (BK) bypass surgery using heparin-bonded expanded polytetrafluoroethylene (ePTFE) grafts, performed in two centers since its launch in Japan.

Methods: We conducted a retrospective analysis of databases from two medical centers, evaluating 51 limbs in 42 consecutive patients with peripheral arterial disease (PAD), who underwent BK bypass surgery using heparin-bonded ePTFE grafts between October, 2013 and April, 2023.

Results: Thirty-three limbs (64.7%) were classified as Rutherford category 4-6 and 33 limbs (64.7%) had a history of ipsilateral revascularization. Technical success was achieved in 98% of the patients. The 30 day mortality rate was 2.4% (n = 1) and the overall 30 day complication rate was 9.5% (n = 4). The median follow-up period was 38 (interquartile range 13-67) months. Three patients required major amputation and 14 died during follow-up. Primary patency rates at 1, 3, and 5 years were 67.8%, 57.5%, and 46.5%, respectively, while secondary patency rates for these periods were 84.6%, 70.0%, and 66.0%, respectively. Overall survival rates at 1, 3, and 5 years were 90.1%, 74.5%, and 70.9%, respectively.

Conclusions: BK bypass surgery using heparin-bonded ePTFE graft is a viable and durable option for patients with PAD, who are deemed unsuitable for autologous vein bypass surgery.

目的:报告使用肝素粘合膨体聚四氟乙烯(ePTFE)移植物的膝下(BK)搭桥手术的疗效:我们对两家医疗中心的数据库进行了回顾性分析,评估了在 2013 年 10 月至 2023 年 4 月期间使用肝素粘合膨体聚四氟乙烯(ePTFE)移植物接受 BK 搭桥手术的 42 名连续外周动脉疾病(PAD)患者的 51 条肢体:33条肢体(64.7%)被归类为卢瑟福4-6类,33条肢体(64.7%)有同侧血管再通史。98%的患者取得了技术成功。30天死亡率为2.4%(1例),30天并发症总发生率为9.5%(4例)。随访时间中位数为 38 个月(四分位数间距为 13-67 个月)。随访期间,3 名患者需要截肢,14 名患者死亡。1年、3年和5年的初次通畅率分别为67.8%、57.5%和46.5%,而这些时期的二次通畅率分别为84.6%、70.0%和66.0%。1年、3年和5年的总存活率分别为90.1%、74.5%和70.9%:结论:对于不适合进行自体静脉搭桥手术的 PAD 患者来说,使用肝素粘合 ePTFE 移植的 BK 搭桥手术是一种可行且持久的选择。
{"title":"Long-term outcomes of below-the-knee bypass surgery using heparin-bonded expanded polytetrafluoroethylene grafts.","authors":"Yohei Yamamoto, Hidetoshi Uchiyama, Masahiro Oonuki, Kazuki Tsukuda, Ai Kazama, Yoshiki Wada, Hiroki Uchiyama, Toru Kikuchi, Masato Nishizawa, Toshifumi Kudo","doi":"10.1007/s00595-024-02898-8","DOIUrl":"10.1007/s00595-024-02898-8","url":null,"abstract":"<p><strong>Purpose: </strong>To report the outcomes of below-the-knee (BK) bypass surgery using heparin-bonded expanded polytetrafluoroethylene (ePTFE) grafts, performed in two centers since its launch in Japan.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of databases from two medical centers, evaluating 51 limbs in 42 consecutive patients with peripheral arterial disease (PAD), who underwent BK bypass surgery using heparin-bonded ePTFE grafts between October, 2013 and April, 2023.</p><p><strong>Results: </strong>Thirty-three limbs (64.7%) were classified as Rutherford category 4-6 and 33 limbs (64.7%) had a history of ipsilateral revascularization. Technical success was achieved in 98% of the patients. The 30 day mortality rate was 2.4% (n = 1) and the overall 30 day complication rate was 9.5% (n = 4). The median follow-up period was 38 (interquartile range 13-67) months. Three patients required major amputation and 14 died during follow-up. Primary patency rates at 1, 3, and 5 years were 67.8%, 57.5%, and 46.5%, respectively, while secondary patency rates for these periods were 84.6%, 70.0%, and 66.0%, respectively. Overall survival rates at 1, 3, and 5 years were 90.1%, 74.5%, and 70.9%, respectively.</p><p><strong>Conclusions: </strong>BK bypass surgery using heparin-bonded ePTFE graft is a viable and durable option for patients with PAD, who are deemed unsuitable for autologous vein bypass surgery.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"222-228"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141627766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The KRAS G12D mutation increases the risk of unresectable recurrence of resectable colorectal liver-only metastasis. KRAS G12D突变增加了可切除结直肠肝转移瘤不可切除复发的风险。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-31 DOI: 10.1007/s00595-024-02900-3
Kai Chen, Yukiyasu Okamura, Keiichi Hatakeyama, Akio Shiomi, Hiroyasu Kagawa, Hitoshi Hino, Shoichi Manabe, Yusuke Yamaoka, Teiichi Sugiura, Takashi Sugino, Akifumi Notsu, Takeshi Nagashima, Keiichi Ohshima, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi

Purpose: Unresectable recurrence is a critical predictor of outcomes for colorectal cancer patients. We attempted to identify the prognostic factors, especially for unresectable recurrence-free survival (URFS) as a new endpoint, in patients with resectable colorectal liver-only metastasis (CRLOM).

Methods: We investigated patients with resectable CRLOM, who underwent an R0 resection for both CRC and CRLOM between January, 2014 and March, 2019 at a single institution. The exclusion criteria were patients who received neoadjuvant treatment, the absence of data for genetic analyses, and the presence of multiple cancers, synchronous CRC, or familial adenomatous polyposis. The prognostic factors were examined retrospectively using data on pre-hepatectomy factors, including primary tumor molecular profiling results.

Results: We analyzed the data of 101 patients who underwent curative-intent surgery for CRLOM. Multivariate analysis revealed that KRAS G12D mutation-positivity (hazard ratio [HR]: 7.69; p < 0.01), RYR2 mutation-positivity (HR: 4.03; p < 0.01), and KRAS G12S mutation-positivity (HR: 3.96; p = 0.03), CA19-9 > 37 U/ml before hepatectomy (HR: 3.62; p < 0.01), and primary tumor pN2 stage (HR: 3.22; p = 0.03) were significant predictors of the URFS.

Conclusions: This is the first study to show that specific KRAS and RYR2 mutations were associated with the URFS.

目的:不可切除复发是预测结直肠癌患者预后的关键因素。我们试图确定可切除结直肠肝转移(CRLOM)患者的预后因素,尤其是作为新终点的不可切除无复发生存期(URFS):我们调查了2014年1月至2019年3月期间在一家机构接受R0切除术的可切除CRLOM患者。排除标准为接受过新辅助治疗的患者、缺乏基因分析数据的患者、患有多种癌症、同步性 CRC 或家族性腺瘤性息肉病的患者。我们利用肝切除术前因素的数据,包括原发肿瘤分子图谱分析结果,对预后因素进行了回顾性研究:我们分析了101例接受治愈性手术治疗的CRLOM患者的数据。多变量分析显示,肝切除术前KRAS G12D突变阳性(危险比[HR]:7.69;P 37 U/ml)(HR:3.62;P 结论:肝切除术前的KRAS G12D突变阳性与肝切除术后的KRAS G12D突变阳性有密切关系:这是首个显示特定 KRAS 和 RYR2 突变与 URFS 相关的研究。
{"title":"The KRAS G12D mutation increases the risk of unresectable recurrence of resectable colorectal liver-only metastasis.","authors":"Kai Chen, Yukiyasu Okamura, Keiichi Hatakeyama, Akio Shiomi, Hiroyasu Kagawa, Hitoshi Hino, Shoichi Manabe, Yusuke Yamaoka, Teiichi Sugiura, Takashi Sugino, Akifumi Notsu, Takeshi Nagashima, Keiichi Ohshima, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi","doi":"10.1007/s00595-024-02900-3","DOIUrl":"10.1007/s00595-024-02900-3","url":null,"abstract":"<p><strong>Purpose: </strong>Unresectable recurrence is a critical predictor of outcomes for colorectal cancer patients. We attempted to identify the prognostic factors, especially for unresectable recurrence-free survival (URFS) as a new endpoint, in patients with resectable colorectal liver-only metastasis (CRLOM).</p><p><strong>Methods: </strong>We investigated patients with resectable CRLOM, who underwent an R0 resection for both CRC and CRLOM between January, 2014 and March, 2019 at a single institution. The exclusion criteria were patients who received neoadjuvant treatment, the absence of data for genetic analyses, and the presence of multiple cancers, synchronous CRC, or familial adenomatous polyposis. The prognostic factors were examined retrospectively using data on pre-hepatectomy factors, including primary tumor molecular profiling results.</p><p><strong>Results: </strong>We analyzed the data of 101 patients who underwent curative-intent surgery for CRLOM. Multivariate analysis revealed that KRAS G12D mutation-positivity (hazard ratio [HR]: 7.69; p < 0.01), RYR2 mutation-positivity (HR: 4.03; p < 0.01), and KRAS G12S mutation-positivity (HR: 3.96; p = 0.03), CA19-9 > 37 U/ml before hepatectomy (HR: 3.62; p < 0.01), and primary tumor pN2 stage (HR: 3.22; p = 0.03) were significant predictors of the URFS.</p><p><strong>Conclusions: </strong>This is the first study to show that specific KRAS and RYR2 mutations were associated with the URFS.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"273-282"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of surgical complications on outcomes of children with hepatoblastoma: a retrospective cohort study. 手术并发症对肝母细胞瘤患儿预后的影响:一项回顾性队列研究。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-08-16 DOI: 10.1007/s00595-024-02906-x
Masahiro Zenitani, Masanori Nishikawa, Ririko Takemura, Daichi Sakai, Masayuki Yoshida, Yuki Noguchi, Rei Matsuura, Satoshi Umeda, Noriaki Usui

Purpose: This study aimed to investigate the incidence of severe surgical complications among children with hepatoblastoma, identify their risk factors, and evaluate the influence of surgical complications on long-term outcomes.

Methods: Children with hepatoblastoma who underwent liver resection at our hospital between September 1992 and January 2023 were included in this study. Clinical data were retrospectively reviewed, and patients were categorized into complication and non-complication groups based on the need for radiological or surgical interventions or massive intraoperative blood loss (> 80 mL/kg).

Results: Out of the 40 patients, 9 experienced severe complications (massive blood loss, n = 7; bile leakage, n = 3; and common bile duct stricture, n = 1). The participation of experienced liver surgeons was significantly greater in the non-complication group than in the complication group. The median duration from surgery to the start of postoperative chemotherapy was significantly shorter in the non-complication group than in the complication group. The overall 5-year survival rate was significantly higher in the non-complication group than in the complication group.

Conclusion: Severe surgical complications were associated with a worse prognosis. An experienced liver surgeon should participate in technically demanding liver resections.

目的:本研究旨在调查肝母细胞瘤患儿严重手术并发症的发生率,确定其风险因素,并评估手术并发症对长期预后的影响:本研究纳入了1992年9月至2023年1月期间在我院接受肝切除术的肝母细胞瘤患儿。回顾性分析临床资料,并根据是否需要放射学或手术干预或术中大量失血(> 80 mL/kg)将患者分为并发症组和非并发症组:40例患者中,9例出现严重并发症(大量失血,7例;胆汁渗漏,3例;胆总管狭窄,1例)。无并发症组中经验丰富的肝脏外科医生的参与率明显高于并发症组。非并发症组从手术到开始术后化疗的中位时间明显短于并发症组。无并发症组的5年总生存率明显高于并发症组:结论:严重的手术并发症与较差的预后有关。有经验的肝脏外科医生应参与技术要求较高的肝脏切除手术。
{"title":"Effect of surgical complications on outcomes of children with hepatoblastoma: a retrospective cohort study.","authors":"Masahiro Zenitani, Masanori Nishikawa, Ririko Takemura, Daichi Sakai, Masayuki Yoshida, Yuki Noguchi, Rei Matsuura, Satoshi Umeda, Noriaki Usui","doi":"10.1007/s00595-024-02906-x","DOIUrl":"10.1007/s00595-024-02906-x","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate the incidence of severe surgical complications among children with hepatoblastoma, identify their risk factors, and evaluate the influence of surgical complications on long-term outcomes.</p><p><strong>Methods: </strong>Children with hepatoblastoma who underwent liver resection at our hospital between September 1992 and January 2023 were included in this study. Clinical data were retrospectively reviewed, and patients were categorized into complication and non-complication groups based on the need for radiological or surgical interventions or massive intraoperative blood loss (> 80 mL/kg).</p><p><strong>Results: </strong>Out of the 40 patients, 9 experienced severe complications (massive blood loss, n = 7; bile leakage, n = 3; and common bile duct stricture, n = 1). The participation of experienced liver surgeons was significantly greater in the non-complication group than in the complication group. The median duration from surgery to the start of postoperative chemotherapy was significantly shorter in the non-complication group than in the complication group. The overall 5-year survival rate was significantly higher in the non-complication group than in the complication group.</p><p><strong>Conclusion: </strong>Severe surgical complications were associated with a worse prognosis. An experienced liver surgeon should participate in technically demanding liver resections.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"197-204"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nipple reconstruction using spiral-peeling technique during oncoplastic breast-conserving surgery for a patient with small breasts. 在为小乳房患者进行肿瘤整形保乳手术时,使用螺旋剥离技术重建乳头。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-05 DOI: 10.1007/s00595-024-02892-0
Yuko Kijima, Munetsugu Hirata, Naotomo Higo, Yumika Nakazawa, Kazuya Shinmura

Treatment of early breast cancer using breast-conserving surgery (BCS) commonly leads to local control and acceptable cosmetic results. We report a useful technique to achieve symmetry of the breast shape and nipple-areola, with excellent results. A Japanese patient with early breast cancer located in the inner central area of the breast was enrolled in this study. Intraductal spread of breast cancer to the nipple was suspected; however, no invasion was observed outside the nipple wall. We preserved the cylindrical surface, but resected the inner tissue with the top surface of the nipple. After coring the nipple, the remnant cylindrical surface was cut into a spiral shape. Nipple reconstruction using the spiral-peeling technique during oncoplastic breast-conserving surgery (OPBCS) may be useful for patients who desire nipple preservation.

采用保乳手术(BCS)治疗早期乳腺癌通常可达到局部控制和可接受的美容效果。我们报告了一种实现乳房形状和乳头乳晕对称的有效技术,效果极佳。本研究选取了一名患有位于乳房内中央区域的早期乳腺癌的日本患者。我们怀疑乳腺癌向乳头的导管内扩散,但在乳头壁外未观察到侵犯。我们保留了乳头的圆柱表面,但切除了内部组织和乳头上表面。对乳头进行取芯后,将残余的圆柱表面切成螺旋状。在肿瘤整形保乳手术(OPBCS)中使用螺旋剥离技术进行乳头重建可能对希望保留乳头的患者有用。
{"title":"Nipple reconstruction using spiral-peeling technique during oncoplastic breast-conserving surgery for a patient with small breasts.","authors":"Yuko Kijima, Munetsugu Hirata, Naotomo Higo, Yumika Nakazawa, Kazuya Shinmura","doi":"10.1007/s00595-024-02892-0","DOIUrl":"10.1007/s00595-024-02892-0","url":null,"abstract":"<p><p>Treatment of early breast cancer using breast-conserving surgery (BCS) commonly leads to local control and acceptable cosmetic results. We report a useful technique to achieve symmetry of the breast shape and nipple-areola, with excellent results. A Japanese patient with early breast cancer located in the inner central area of the breast was enrolled in this study. Intraductal spread of breast cancer to the nipple was suspected; however, no invasion was observed outside the nipple wall. We preserved the cylindrical surface, but resected the inner tissue with the top surface of the nipple. After coring the nipple, the remnant cylindrical surface was cut into a spiral shape. Nipple reconstruction using the spiral-peeling technique during oncoplastic breast-conserving surgery (OPBCS) may be useful for patients who desire nipple preservation.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"288-292"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141538679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive modeling for the germline pathogenic variant of the APC gene in patients with adenomatous polyposis: proposing a new APC score. 腺瘤性息肉病患者 APC 基因种系致病变体的预测模型:提出新的 APC 评分。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-06 DOI: 10.1007/s00595-024-02894-y
Misato Takao, Tatsuro Yamaguchi, Hidetaka Eguchi, Okihide Suzuki, Yoshiko Mori, Noriyasu Chika, Takeshi Yamada, Yasushi Okazaki, Naohiro Tomita, Tadashi Nomizu, Tomoyuki Momma, Tetsuji Takayama, Kohji Tanakaya, Kiwamu Akagi, Noriko Tanabe, Hideyuki Ishida

Background: The precise diagnosis and medical management of patients with suspected familial adenomatous polyposis should be based on genetic testing, which may not always be available. Therefore, establishing a new model for predicting the likelihood of a germline pathogenic variant (GPV) of APC based on its clinical manifestations could prove to be useful in clinical practice.

Methods: The presence of GPVs of APC gene was investigated in 162 patients with adenomatous polyposis (≥ 10 polyps) using a multigene panel or single-gene testing. To generate a predictive model for GPV of the APC gene, a logistic regression analysis was performed using the clinicopathological variables available at the time of the diagnosis of adenomatous polyposis.

Results: Ninety (55.6%) patients had GPV of the APC gene. According to a multivariate logistic regression analysis, age < 40 years, polyps ≥ 100, fundic gland polyposis, and a family history of colorectal polyposis were found to be independent predictors of the GPV of APC and were used to establish a formula for predicting the GPV of APC using the four predictors. The prediction model had an area under the curve of 0.91 (0.86-0.96) according to a receiver operating characteristic analysis.

Conclusion: The model for predicting the GPV of APC will help patients with adenomatous polyposis and physicians make decisions about genetic testing.

背景:对疑似家族性腺瘤性息肉病患者的精确诊断和医疗管理应以基因检测为基础,但基因检测并不总是可用的。因此,根据临床表现建立一个预测 APC 基因种系致病变体(GPV)可能性的新模型,可能会在临床实践中发挥作用:方法:采用多基因检测或单基因检测,对 162 名腺瘤性息肉病(息肉≥ 10 个)患者的 APC 基因 GPV 存在情况进行了调查。为了建立 APC 基因 GPV 的预测模型,利用诊断腺瘤性息肉病时的临床病理变量进行了逻辑回归分析:结果:90 名患者(55.6%)患有 APC 基因 GPV。根据多变量逻辑回归分析,年龄预测 APC GPV 的模型将有助于腺瘤性息肉病患者和医生做出基因检测的决定。
{"title":"Predictive modeling for the germline pathogenic variant of the APC gene in patients with adenomatous polyposis: proposing a new APC score.","authors":"Misato Takao, Tatsuro Yamaguchi, Hidetaka Eguchi, Okihide Suzuki, Yoshiko Mori, Noriyasu Chika, Takeshi Yamada, Yasushi Okazaki, Naohiro Tomita, Tadashi Nomizu, Tomoyuki Momma, Tetsuji Takayama, Kohji Tanakaya, Kiwamu Akagi, Noriko Tanabe, Hideyuki Ishida","doi":"10.1007/s00595-024-02894-y","DOIUrl":"10.1007/s00595-024-02894-y","url":null,"abstract":"<p><strong>Background: </strong>The precise diagnosis and medical management of patients with suspected familial adenomatous polyposis should be based on genetic testing, which may not always be available. Therefore, establishing a new model for predicting the likelihood of a germline pathogenic variant (GPV) of APC based on its clinical manifestations could prove to be useful in clinical practice.</p><p><strong>Methods: </strong>The presence of GPVs of APC gene was investigated in 162 patients with adenomatous polyposis (≥ 10 polyps) using a multigene panel or single-gene testing. To generate a predictive model for GPV of the APC gene, a logistic regression analysis was performed using the clinicopathological variables available at the time of the diagnosis of adenomatous polyposis.</p><p><strong>Results: </strong>Ninety (55.6%) patients had GPV of the APC gene. According to a multivariate logistic regression analysis, age < 40 years, polyps ≥ 100, fundic gland polyposis, and a family history of colorectal polyposis were found to be independent predictors of the GPV of APC and were used to establish a formula for predicting the GPV of APC using the four predictors. The prediction model had an area under the curve of 0.91 (0.86-0.96) according to a receiver operating characteristic analysis.</p><p><strong>Conclusion: </strong>The model for predicting the GPV of APC will help patients with adenomatous polyposis and physicians make decisions about genetic testing.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"229-237"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141545300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of preoperative skeletal muscle loss on the completion of S-1 adjuvant chemotherapy for gastric cancer. 术前骨骼肌缺失对完成胃癌 S-1 辅助化疗的影响。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-07-30 DOI: 10.1007/s00595-024-02902-1
Yudai Nakabayashi, Takuma Ohashi, Takeshi Kubota, Keiji Nishibeppu, Masayuki Yubakami, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Eigo Otsuji

Purpose: Body weight loss after surgery for gastric cancer is related to S-1 compliance and it also affects the prognosis. However, it is unclear whether the preoperative skeletal muscle mass affects S-1 completion for gastric cancer. We investigated the impact of preoperative skeletal muscle mass loss on the completion of S-1 adjuvant chemotherapy for gastric cancer.

Methods: We retrospectively analyzed data from 53 patients who underwent curative gastrectomy followed by adjuvant S-1 monotherapy for pStage II-III gastric cancer between 2012 and 2021 at our hospital. The psoas muscle mass index (PMI) was used as the index for preoperative skeletal muscle mass.

Results: Thirty-six patients completed S-1 treatment and 17 discontinued treatment. The patients who completed S-1 treatment had a longer overall survival than those who discontinued treatment (log-rank test, p = 0.043). According to a univariate analysis, the patients in the discontinuation group had a significantly lower preoperative body mass index (< 22.9 kg/m2, p = 0.005) and a higher rate of adverse events (grade 2 or higher, p < 0.001) than those in the completion group. According to a multivariate analysis, preoperative PMI (HR 3.563, p = 0.030) was an independent predictive factor for S-1 completion.

Conclusion: Preoperative skeletal muscle loss might therefore prevent the completion of adjuvant chemotherapy S-1 in patients with gastric cancer.

目的:胃癌术后体重减轻与 S-1 顺应性有关,也会影响预后。然而,目前还不清楚术前骨骼肌质量是否会影响胃癌 S-1 治疗的完成。我们研究了术前骨骼肌质量损失对胃癌 S-1 辅助化疗完成度的影响:我们回顾性分析了 2012 年至 2021 年期间在我院接受治愈性胃切除术并接受 S-1 单药辅助治疗的 53 例 II-III 期胃癌患者的数据。腰肌质量指数(PMI)被用作术前骨骼肌质量的指标:结果:36 名患者完成了 S-1 治疗,17 名患者中止了治疗。与中止治疗的患者相比,完成 S-1 治疗的患者总生存期更长(log-rank 检验,P = 0.043)。根据单变量分析,中止治疗组患者的术前体重指数(2,P = 0.005)明显较低,不良事件发生率较高(2 级或以上,P 结论:术前骨骼肌损失可能是导致术后骨质疏松症的原因之一:因此,术前骨骼肌损失可能会阻碍胃癌患者完成辅助化疗 S-1。
{"title":"The impact of preoperative skeletal muscle loss on the completion of S-1 adjuvant chemotherapy for gastric cancer.","authors":"Yudai Nakabayashi, Takuma Ohashi, Takeshi Kubota, Keiji Nishibeppu, Masayuki Yubakami, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Eigo Otsuji","doi":"10.1007/s00595-024-02902-1","DOIUrl":"10.1007/s00595-024-02902-1","url":null,"abstract":"<p><strong>Purpose: </strong>Body weight loss after surgery for gastric cancer is related to S-1 compliance and it also affects the prognosis. However, it is unclear whether the preoperative skeletal muscle mass affects S-1 completion for gastric cancer. We investigated the impact of preoperative skeletal muscle mass loss on the completion of S-1 adjuvant chemotherapy for gastric cancer.</p><p><strong>Methods: </strong>We retrospectively analyzed data from 53 patients who underwent curative gastrectomy followed by adjuvant S-1 monotherapy for pStage II-III gastric cancer between 2012 and 2021 at our hospital. The psoas muscle mass index (PMI) was used as the index for preoperative skeletal muscle mass.</p><p><strong>Results: </strong>Thirty-six patients completed S-1 treatment and 17 discontinued treatment. The patients who completed S-1 treatment had a longer overall survival than those who discontinued treatment (log-rank test, p = 0.043). According to a univariate analysis, the patients in the discontinuation group had a significantly lower preoperative body mass index (< 22.9 kg/m<sup>2</sup>, p = 0.005) and a higher rate of adverse events (grade 2 or higher, p < 0.001) than those in the completion group. According to a multivariate analysis, preoperative PMI (HR 3.563, p = 0.030) was an independent predictive factor for S-1 completion.</p><p><strong>Conclusion: </strong>Preoperative skeletal muscle loss might therefore prevent the completion of adjuvant chemotherapy S-1 in patients with gastric cancer.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"238-246"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic factors for intraductal papillary neoplasm of the bile duct following surgical resection: a systematic review and meta-analysis. 手术切除后胆管导管内乳头状肿瘤的预后因素:系统回顾和荟萃分析。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-10-18 DOI: 10.1007/s00595-024-02948-1
Di Zeng, Bei Li, Nansheng Cheng

Intraductal papillary neoplasm of the bile duct (IPNB) is a biliary neoplasm characterized by intraductal papillary growth and varying degrees of malignant transformation. This study aimed to identify effective prognostic factors (PFs) for predicting the prognosis of IPNB after surgical resection, addressing the gap in the higher level evidence. We systematically searched databases from their inception to October 10, 2023. Data on 12 predetermined PFs were collected and subjected to a meta-analysis. Forest plots were used to summarize the findings. Fifteen studies with a total of 2311 patients were included. Among the PFs examined, extrahepatic tumor location (HR, 2.97; 95% CI 1.68-5.23), subclassification type 2 (HR, 2.62; 95% CI 1.45-4.76), R1 resection (HR, 2.47; 95% CI 1.73-3.51), elevated CA19-9 level (HR, 3.25; 95% CI 1.91-5.54), tumor multiplicity (HR, 2.65; 95% CI 1.40-5.02), and adjacent organ invasion (HR, 3.17; 95% CI 2.01-5.00) were associated with a poorer prognosis. Additionally, the combined HR values indicated that lymph node metastasis and poor tumor differentiation were linked to a worse prognosis, although both exhibited significant heterogeneity. Our study offers valuable insights for enhancing postoperative prognostication and treatment decision-making for IPNB patients with IPNB. These findings warrant further validation in future prospective studies.

胆管导管内乳头状瘤(IPNB)是一种胆道肿瘤,其特点是导管内乳头状生长和不同程度的恶性转化。本研究旨在找出预测 IPNB 手术切除后预后的有效预后因素 (PF),弥补高水平证据的不足。我们系统地检索了从开始到 2023 年 10 月 10 日的数据库。收集了 12 个预定 PFs 的数据并进行了荟萃分析。森林图用于总结研究结果。共纳入了 15 项研究,共计 2311 名患者。51)、CA19-9水平升高(HR,3.25;95% CI 1.91-5.54)、肿瘤多发性(HR,2.65;95% CI 1.40-5.02)和邻近器官侵犯(HR,3.17;95% CI 2.01-5.00)与预后较差有关。此外,综合 HR 值表明,淋巴结转移和肿瘤分化不良与较差的预后有关,尽管两者都表现出显著的异质性。我们的研究为改善 IPNB 患者的术后预后和治疗决策提供了有价值的见解。这些发现值得在未来的前瞻性研究中进一步验证。
{"title":"Prognostic factors for intraductal papillary neoplasm of the bile duct following surgical resection: a systematic review and meta-analysis.","authors":"Di Zeng, Bei Li, Nansheng Cheng","doi":"10.1007/s00595-024-02948-1","DOIUrl":"10.1007/s00595-024-02948-1","url":null,"abstract":"<p><p>Intraductal papillary neoplasm of the bile duct (IPNB) is a biliary neoplasm characterized by intraductal papillary growth and varying degrees of malignant transformation. This study aimed to identify effective prognostic factors (PFs) for predicting the prognosis of IPNB after surgical resection, addressing the gap in the higher level evidence. We systematically searched databases from their inception to October 10, 2023. Data on 12 predetermined PFs were collected and subjected to a meta-analysis. Forest plots were used to summarize the findings. Fifteen studies with a total of 2311 patients were included. Among the PFs examined, extrahepatic tumor location (HR, 2.97; 95% CI 1.68-5.23), subclassification type 2 (HR, 2.62; 95% CI 1.45-4.76), R1 resection (HR, 2.47; 95% CI 1.73-3.51), elevated CA19-9 level (HR, 3.25; 95% CI 1.91-5.54), tumor multiplicity (HR, 2.65; 95% CI 1.40-5.02), and adjacent organ invasion (HR, 3.17; 95% CI 2.01-5.00) were associated with a poorer prognosis. Additionally, the combined HR values indicated that lymph node metastasis and poor tumor differentiation were linked to a worse prognosis, although both exhibited significant heterogeneity. Our study offers valuable insights for enhancing postoperative prognostication and treatment decision-making for IPNB patients with IPNB. These findings warrant further validation in future prospective studies.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"131-143"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery Today
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1